- Rezolute furnished an updated corporate presentation under Item 7.01.
- Highlights clinical data for lead asset RZ358 in refractory hypoglycemia.
- Standard non-binding presentation filing with no material new financials.
? Neutral AI Sentiment (+0.5 / 10)